Abstract
It has been suggested that more than 70% of the renal cysts in patients with autosomal dominant polycystic kidney disease (ADPKD) arise from the collecting duct and that within this segment cysts originate almost exclusively from principal rather than intercalated cells. The mechanisms for this predisposition of principal cells have so far remained elusive. We, therefore, used Madin–Darby canine kidney (MDCK) subclones resembling principal cells and alpha-intercalated cells in a three-dimensional in vitro model to determine differences in cystogenesis and cyst growth, including the response to cyclic adenosine monophosphate (cAMP) elevation and the dependence on ATP signaling. We found that in vitro cysts developed only from principal-like but not from intercalated-like MDCK cell clones. This specificity could be verified in mixed MDCK cultures enriched for principal- or intercalated-like cells. In vitro cyst growth upon elevation of intracellular cAMP was mainly driven by fluid secretion, rather than increased cell proliferation. The cAMP-dependent fluid secretion was found to depend on extracellular adenosine-5'-triphosphate (ATP) and to act synergistically with purinergic signaling, as the use of the ATP scavenger apyrase, as well as the P2 receptor inhibitor suramin, reduced cAMP-driven fluid secretion, while increasing extracellular ATP potentiated cAMP-mediated cyst growth. In conclusion, we provide in vitro evidence for the ability of principal rather than intercalated cells to form cysts, based on a synergism of cAMP and ATP signaling in enhancing apical fluid secretion.
Similar content being viewed by others
References
Arnaout MA (2001) Molecular genetics and pathogenesis of autosomal dominant polycystic kidney disease. Annu Rev Med 52:93–123
Grantham JJ, Ye M, Gattone VH 2nd, Sullivan LP (1995) In vitro fluid secretion by epithelium from polycystic kidneys. J Clin Invest 95:195–202
Mangoo-Karim R, Uchic M, Lechene C, Grantham JJ (1989) Renal epithelial cyst formation and enlargement in vitro: dependence on cAMP. Proc Natl Acad Sci USA 86:6007–6011
Shillingford JM, Murcia NS, Larson CH, Low SH, Hedgepeth R, Brown N, Flask CA, Novick AC, Goldfarb DA, Kramer-Zucker A, Walz G, Piontek KB, Germino GG, Weimbs T (2006) The mTOR pathway is regulated by polycystin-1, and its inhibition reverses renal cystogenesis in polycystic kidney disease. Proc Natl Acad Sci USA 103:5466–5471
Torres VE (2004) Cyclic AMP, at the hub of the cystic cycle. Kidney Int 66:1283–1285
Torres VE, Harris PC, Pirson Y (2007) Autosomal dominant polycystic kidney disease. Lancet 369:1287–1301
Raphael KL, Strait KA, Stricklett PK, Miller RL, Nelson RD, Piontek KB, Germino GG, Kohan DE (2009) Inactivation of Pkd1 in principal cells causes a more severe cystic kidney disease than in intercalated cells. Kidney Int 75:626–633
Gekle M, Wunsch S, Oberleithner H, Silbernagl S (1994) Characterization of two MDCK-cell subtypes as a model system to study principal cell and intercalated cell properties. Pflugers Arch 428:157–162
Turner CM, King BF, Srai KS, Unwin RJ (2007) Antagonism of endogenous putative P2Y receptors reduces the growth of MDCK-derived cysts cultured in vitro. Am J Physiol Ren Physiol 292:F15–F25
Arthur JM (2000) The MDCK cell line is made up of populations of cells with diverse resistive and transport properties. Tissue Cell 32:446–450
Wunsch S, Gekle M, Kersting U, Schuricht B, Oberleithner H (1995) Phenotypically and karyotypically distinct Madin-Darby canine kidney cell clones respond differently to alkaline stress. J Cell Physiol 164:164–171
Graness A, Cicha I, Goppelt-Struebe M (2006) Contribution of Src-FAK signaling to the induction of connective tissue growth factor in renal fibroblasts. Kidney Int 69:1341–1349
LeHir M, Kaissling B, Koeppen BM, Wade JB (1982) Binding of peanut lectin to specific epithelial cell types in kidney. Am J Physiol 242:C117–C120
Grantham JJ, Geiser JL, Evan AP (1987) Cyst formation and growth in autosomal dominant polycystic kidney disease. Kidney Int 31:1145–1152
Leipziger J (2003) Control of epithelial transport via luminal P2 receptors. Am J Physiol Ren Physiol 284:F419–F432
Bourcier N, Grygorczyk R, Gekle M, Berthiaume Y, Orlov SN (2002) Purinergic-induced ion current in monolayers of C7-MDCK cells: role of basolateral and apical ion transporters. J Membr Biol 186:131–143
von Kugelgen I (2006) Pharmacological profiles of cloned mammalian P2Y-receptor subtypes. Pharmacol Ther 110:415–432
Harris PC, Torres VE (2009) Polycystic kidney disease. Annu Rev Med 60:321–337
Schwiebert EM, Wallace DP, Braunstein GM, King SR, Peti-Peterdi J, Hanaoka K, Guggino WB, Guay-Woodford LM, Bell PD, Sullivan LP, Grantham JJ, Taylor AL (2002) Autocrine extracellular purinergic signaling in epithelial cells derived from polycystic kidneys. Am J Physiol Ren Physiol 282:F763–F775
Wilson PD, Hovater JS, Casey CC, Fortenberry JA, Schwiebert EM (1999) ATP release mechanisms in primary cultures of epithelia derived from the cysts of polycystic kidneys. J Am Soc Nephrol 10:218–229
Lazarowski ER, Boucher RC (2001) UTP as an extracellular signaling molecule. News Physiol Sci 16:1–5
Praetorius HA, Frokiaer J, Leipziger J (2005) Transepithelial pressure pulses induce nucleotide release in polarized MDCK cells. Am J Physiol Ren Physiol 288:F133–F141
Brindikova TA, Bourcier N, Torres B, Pchejetski D, Gekle M, Maximov GV, Montminy V, Insel PA, Orlov SN, Isenring P (2003) Purinergic-induced signaling in C11-MDCK cells inhibits the secretory Na-K-Cl cotransporter. Am J Physiol Cell Physiol 285:C1445–C1453
Cuffe JE, Bielfeld-Ackermann A, Thomas J, Leipziger J, Korbmacher C (2000) ATP stimulates Cl− secretion and reduces amiloride-sensitive Na+ absorption in M-1 mouse cortical collecting duct cells. J Physiol 524(Pt 1):77–90
Akimova AO, Bourcier N, Taurin S, Bundey RA, Grygorczyk K, Gekle M, Insel PA, Dulin NO, Orlov SN (2005) Cl- secretion in ATP-treated renal epithelial C7-MDCK cells is mediated by activation of P2Y1 receptors, phospholipase A2 and protein kinase A. J Physiol 568:789–801
Akimova OA, Taurin S, Dulin NO, Orlov SN (2008) Purinergic inhibition of Na(+), K (+), Cl (−) cotransport in C11-MDCK cells: role of stress-activated protein kinases. Purinergic Signal 4:183–191
Cressman VL, Lazarowski E, Homolya L, Boucher RC, Koller BH, Grubb BR (1999) Effect of loss of P2Y(2) receptor gene expression on nucleotide regulation of murine epithelial Cl(−) transport. J Biol Chem 274:26461–26468
Lazarowski ER, Paradiso AM, Watt WC, Harden TK, Boucher RC (1997) UDP activates a mucosal-restricted receptor on human nasal epithelial cells that is distinct from the P2Y2 receptor. Proc Natl Acad Sci USA 94:2599–2603
Deetjen P, Thomas J, Lehrmann H, Kim SJ, Leipziger J (2000) The luminal P2Y receptor in the isolated perfused mouse cortical collecting duct. J Am Soc Nephrol 11:1798–1806
Turner CM, Ramesh B, Srai SK, Burnstock G, Unwin RJ (2004) Altered ATP-sensitive P2 receptor subtype expression in the Han:SPRD cy/+ rat, a model of autosomal dominant polycystic kidney disease. Cells Tissues Organs 178:168–179
Torres VE (2008) Vasopressin antagonists in polycystic kidney disease. Semin Nephrol 28:306–317
Acknowledgments
We thank Hans Oberleithner and Marianne Wilhelmi from the University of Muenster for the kind gift of the C7 and C11 clones. We also thank Margarete Goppelt-Struebe and Carsten Willam for their helpful discussions and technical support and Michael Köttgen for his critical reading of the manuscript. B. Buchholz was a recipient of a stipend from the ELAN-Fonds (Erlanger Leistungsbezogene Anschubfinanzierung und Nachwuchsförderung) and is supported by a junior career development grant of the Interdisciplinary Center of Clinical Research at the University of Erlangen-Nuremberg.
Disclosure statement
No disclosures.
Author information
Authors and Affiliations
Corresponding authors
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Buchholz, B., Teschemacher, B., Schley, G. et al. Formation of cysts by principal-like MDCK cells depends on the synergy of cAMP- and ATP-mediated fluid secretion. J Mol Med 89, 251–261 (2011). https://doi.org/10.1007/s00109-010-0715-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00109-010-0715-1